Inj. insulin degludec with insulin aspart

Insulin degludec (2.56mg) insulin aspart (1.05mg) , 3ml prefilled pen

Inj. insulin degludec 100 i.u.

Hq_med_gte_zrc_zonal rate contract for supply of (ph no.:31280) monocomponent biosynthetic r-dna insulin solution for injecton in cartridge 70 percent insulin degludec + 30 percent insulin aspart - 100 u/ml - 3 ml

Insuline degludec inj 100iu/ml prefilled pen

Inj. biosynthetic r-dna origin mixture of 50 percent soluble insulin aspart (rys) and 50 percent protamine crystallised insulin aspart 100iu/ml 03 ml cartridge with complimentary pen and ultrafine nano needle.

Insulin degludec (r-dna origin)100iu/ml in 3ml penfills

Inj.insulin aspart (30 percent ) + insulin aspart protamine (70 percent ) cartridge

Inj tirzepatide 2.5 mg,inj tirzepatide 5 mg,inj tirzepatide7. 5 mg,inj tirzepatide 10 mg,tab acalabrutinib 100 mg,tab niraparib 100 mg,inj insulin aspart analogue rapid acting 100 iuperml 3 ml pfs,inj tislelizumab 100 mg 10 ml vial

Hq_med_drugs_gte_zrc_zonal rate contract for supply of (ph no.:10088) insulin degludec 100 u/ml - 3 ml pre filled pen